Skip to main content
$1.62 At close · Jul 27
Market Cap
$4.90M
Shares
3.09M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$5.31M -1.9%
FY2025 Revenue FY2012–FY2025
Net Income
-$4.97M +16.8%
FY2025 Net Income FY2012–FY2025
Gross Margin
9.38% -1.9pp
FY2025 Gross Margin FY2012–FY2025
Operating Margin
-96.72% +20.9pp
FY2025 Operating Margin FY2012–FY2025
Diluted EPS
-$2.16 +25%
FY2025 Diluted EPS FY2012–FY2025
Operating Cash Flow
-$3.84M +28.4%
FY2025 Operating Cash Flow FY2012–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
$4.33M $5.31M $5.42M $5.34M $18.87M $7.2M $6.69M $5.2M $5.56M $5.79M $5.14M $4.96M $5.12M $6.47M $6.08M
$1.25M $165K $431K
$4.14M $4.81M $4.8M $4.89M $15.89M $6.83M $4.91M $3.91M $3.81M $3.77M $3.62M $3.42M $3.45M $4.05M $3.78M
$184K $498K $611K $446K $2.98M $366.29K $1.78M $1.29M $1.75M $2.02M $1.52M $1.54M $1.67M $2.43M $2.3M
9.38% 11.28% 8.35% 15.78% 5.09% 26.62% 24.84% 31.53% 34.91% 29.65% 31.07% 32.6% 37.51% 37.78%
$835K $1.02M $1.49M $1.58M $1.81M $2.47M $1.91M $1.68M $1.4M $1.13M $780.33K $733.64K $589.87K $459.09K $347.13K
$1.72M $1.63M
$2.98M
$4.7M $4.61M $5.49M $6.09M $5.7M $5.39M $2.27M $2.03M $1.84M $1.85M $1.57M $1.48M $1.53M $1.45M $1.45M
$24K $21K $18K $18K $239K $33.55K $23.87K $61.69K $75.55K $74.33K $76.14K $75.06K $29.52K $29.38K
$87K $81K $84K $100K $104.72K $105.3K $101.22K $111.06K $144.89K $156.28K $178.22K $177.52K $187.33K $147.3K
$5.54M $5.64M $6.98M $7.67M $7.51M $7.87M $4.18M $3.7M $3.24M $2.98M $2.35M $2.21M $2.12M $1.91M $1.79M
-$5.36M -$5.14M -$6.37M -$7.22M -$4.53M -$7.5M -$2.4M -$2.41M -$1.48M -$954.63K -$826.95K -$670.6K -$446.59K $514.01K $505K
-96.72% -117.58% -135.29% -24.03% -104.18% -35.9% -46.39% -26.63% -16.48% -16.09% -13.51% -8.72% 7.94% 8.3%
-$5.05M -$6.29M -$7.14M -$4.43M -$7.39M -$2.3M -$2.31M -$1.37M -$809.75K -$670.67K -$492.38K -$269.08K $701.33K $652.3K
$367 $367 $9 $47 $37 $282 $167 $142 $142 $302 $1585
$1.2M $165K $431K $134K $26.64K $66.5K $71.18K $43.97K $47.73K $46.07K $30.97K $24.16K $20.17K $10.46K $108.45K
-$4.15M -$4.97M -$5.94M -$7.09M -$4.51M -$7.43M -$2.33M -$2.37M -$1.43M -$908.56K -$795.99K -$646.43K -$426.42K $524.46K
$20K $1000 $42K $51K $23.72K $13.06K $7390 $24.24K $31.8K $703.8K $703.8K -$315.02K -$210.76K -$12.49K $65.01K
-$4.17M -$4.97M -$5.98M -$7.14M -$4.53M -$7.45M -$2.34M -$2.39M -$1.47M -$908.56K -$1.5M -$331.41K -$215.66K $536.96K $548.44K
-93.64% -110.4% -133.73% -24.01% -103.43% -34.95% -46.01% -26.34% -15.69% -29.18% -6.68% -4.21% 8.3% 9.02%
-$4.17M -$4.98M -$5.97M -$7.18M -$4.56M -$7.45M -$2.34M -$2.4M -$1.48M -$910.81K -$1.5M -$333.53K -$216.8K $533.98K $546.87K
USD/shares -$2.16 -$2.88 -$4.00 -$2.88 -$4.96 -$1.84 -$2.08 -$1.36 -$0.88 -$1.60 -$0.32 -$0.24 $0.64 $0.64
USD/shares -$2.16 -$2.88 -$4.00 -$2.88 -$4.96 -$1.84 -$2.08 -$1.36 -$0.88 -$1.60 -$0.32 -$0.24 $0.56 $0.64
shares 2.3M 2.1M 1.77M 1.58M 1.49M 1.27M 1.15M 1.07M 1.04M 953.26K 944.03K 921.35K 878.05K
shares 2.3M 2.1M 1.77M 1.58M 1.49M 1.27M 1.15M 1.07M 1.04M 953.26K 944.03K 921.35K 931.39K 888.47K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 0.57×
EV/EBIT
P/E (TTM)
Peer median 1.44×

Peer medians compare against the 49 similar-size Medical Devices companies (of 146 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2022 FY2021
Physicians Office $14,259,000 $2,801,000
Clinical Lab $3,064,000 $3,077,000
Over the Counter $1,089,000 $766,000
Contract Manufacturing $459,000 $555,000

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022
Asia $1,718,000 $1,881,000 $2,021,000 $13,375,000
North America $1,658,000 $1,285,000 $1,470,000 $997,000
Europe $1,297,000 $1,438,000 $1,798,000 $4,339,000
Middle East $630,000 $800,000 $39,000 $70,000
South America $8,000 $11,000 $11,000 $90,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022
Clinical Lab $3,181,000 $3,236,000 $3,310,000 $3,064,000
Contract Manufacturing $1,070,000 $741,000 $610,000 $459,000
Over the Counte $1,049,000 $1,426,000 $1,169,000 $1,089,000
Physicians Office $11,000 $12,000 $250,000 $14,259,000
Key facts CIK 73290 CUSIP 09061H406 Visit website Investor relations